# Targeted Axillary Dissection After Neo-adjuvant Chemotherapy

> **NCT05071911** · — · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** TAD (Targeted Axillary Dissection)

## Key facts

- **NCT ID:** NCT05071911
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-21
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05071911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05071911, "Targeted Axillary Dissection After Neo-adjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05071911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*